Related Articles
Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells
YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer
YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and in vivo
Survivin selective inhibitor YM155 promotes cisplatin‑induced apoptosis in embryonal rhabdomyosarcoma
Silencing of survivin by YM155 induces apoptosis and growth arrest in hepatocellular carcinoma cells